145 related articles for article (PubMed ID: 16491875)
1. [Disc neovascularization in a patient with Vogt-Koyanagi-Harada disease and efficacy of steroid pulse therapy].
Kawaguchi T; Yokota M; Sugita S; Mochizuki M
Nippon Ganka Gakkai Zasshi; 2006 Jan; 110(1):58-60. PubMed ID: 16491875
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
Nakayama M; Keino H; Watanabe T; Okada AA
Br J Ophthalmol; 2019 Feb; 103(2):274-278. PubMed ID: 29666121
[TBL] [Abstract][Full Text] [Related]
4. Vogt-Koyanagi-Harada disease.
O'Keefe GA; Rao NA
Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
[TBL] [Abstract][Full Text] [Related]
5. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
6. Choroidal thickness in convalescent vogt-koyanagi-harada disease.
Takahashi H; Takase H; Ishizuka A; Miyanaga M; Kawaguchi T; Ohno-Matsui K; Mochizuki M
Retina; 2014 Apr; 34(4):775-80. PubMed ID: 23979311
[TBL] [Abstract][Full Text] [Related]
7. [Vogt-Koyanagi-Harada syndrome in children].
Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
[TBL] [Abstract][Full Text] [Related]
8. [A case of anterior ischemic optic neuropathy associated with Vogt-Koyanagi-Harada disease].
Abematsu N; Shimonagano Y; Nakao K; Sakamoto T; Shimizu K; Hirashima S
Nippon Ganka Gakkai Zasshi; 2006 Aug; 110(8):601-6. PubMed ID: 16972652
[TBL] [Abstract][Full Text] [Related]
9. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Sasamoto Y; Ohno S; Matsuda H
Ophthalmologica; 1990; 201(3):162-7. PubMed ID: 2089358
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
Read RW; Yu F; Accorinti M; Bodaghi B; Chee SP; Fardeau C; Goto H; Holland GN; Kawashima H; Kojima E; Lehoang P; Lemaitre C; Okada AA; Pivetti-Pezzi P; Secchi A; See RF; Tabbara KF; Usui M; Rao NA
Am J Ophthalmol; 2006 Jul; 142(1):119-24. PubMed ID: 16815259
[TBL] [Abstract][Full Text] [Related]
11. Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease.
Miyanaga M; Kawaguchi T; Shimizu K; Miyata K; Mochizuki M
Int Ophthalmol; 2007; 27(2-3):183-8. PubMed ID: 17476572
[TBL] [Abstract][Full Text] [Related]
12. Mutton fat-like subretinal precipitates associated with Vogt-Koyanagi-Harada disease.
Hamabata K; Hashizume K; Ishikawa Y; Fujiwara T; Machida S; Kurosaka D
Ocul Immunol Inflamm; 2010 Jan; 18(1):44-5. PubMed ID: 20128649
[TBL] [Abstract][Full Text] [Related]
13. Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
Gruich MJ; Evans OB; Storey JM; Bradley ST; Chen CJ
Pediatr Neurol; 1995 Jul; 13(1):50-1. PubMed ID: 7575849
[TBL] [Abstract][Full Text] [Related]
14. Conjunctival nodules associated with Vogt-Koyanagi-Harada disease.
Nakao K; Shimonagano Y; Doi N; Sakamoto T
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1383-6. PubMed ID: 17701198
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
[TBL] [Abstract][Full Text] [Related]
16. [Steroid Resistant Vogt-Koyanagi-Harada Disease Treated Effectively with Cyclosporine].
Fukutomi A; Mashimo H; Yoshioka M; Haruta M; Minami T; Shimojo H; Ohguro N
Nippon Ganka Gakkai Zasshi; 2017 Jun; 121(6):480-6. PubMed ID: 30088715
[TBL] [Abstract][Full Text] [Related]
17. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.
Keino H; Goto H; Usui M
Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):878-82. PubMed ID: 12397437
[TBL] [Abstract][Full Text] [Related]
18. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.
Kawaguchi T; Horie S; Bouchenaki N; Ohno-Matsui K; Mochizuki M; Herbort CP
Int Ophthalmol; 2010 Feb; 30(1):41-50. PubMed ID: 19151926
[TBL] [Abstract][Full Text] [Related]
19. [The Vogt-Koyanagi-Harada syndrome in 11-year-old girl].
Swiech-Zubilewicz A; Wróblewska E; Mańkowska A
Klin Oczna; 2005; 107(7-9):511-4. PubMed ID: 16417010
[TBL] [Abstract][Full Text] [Related]
20. Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.
Abu El-Asrar AM; Al Mudhaiyan T; Al Najashi AA; Hemachandran S; Hariz R; Mousa A; Al-Muammar A
Ocul Immunol Inflamm; 2017 Aug; 25(4):475-485. PubMed ID: 27003480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
